Sector News

Agfa HealthCare acquires TIP Group

January 12, 2016
Life sciences

Agfa HealthCare announces today, that it has acquired the TIP Group, which is based in Graz, Austria. This merger of two healthcare pioneers will broaden Agfa HealthCare’s portfolio with specialized Business Intelligence and ERP solutions for hospitals.

Specialized tools for Business Intelligence
“The merger with the TIP Group will give us access to a specialist in hospital Business Intelligence, with solutions that will extend our global offering in a meaningful way,” says Winfried Post, CEO and General Manager, Agfa HealthCare GmbH. “Business Intelligence solutions are ever-more important for hospitals. The increasing cost pressures in healthcare will only be efficiently managed in the future using specialized tools. With this acquisition, we now have a solution that is tailored to the data integration and analysis needs of the hospital, allowing us to generate an even higher added value for healthcare facilities.”

Agfa HealthCare (agfahealthcare.com) and the TIP Group (tip-ag.com) both have long-standing experience in healthcare and in the optimization of processes. Combined with deep insight into hospital workflows, this will enable the advantages of a joint future will be realized quickly, and an extremely powerful team will emerge from the merger.

Extended portfolio of solutions
“The acquisition by Agfa HealthCare opens up new possibilities for our comprehensive product portfolio,” says Heimo Babcicky, chairman and founder of the TIP Group. “Agfa HealthCare is a strong and solid partner for us and for our customers, which enables us to jointly offer a larger portfolio. In this way, our solutions improve and our customers benefit from our cooperation.”

The new partners will begin working together immediately, to mutually make the change for a successful future.

Source: Agfa HealthCare

comments closed

Related News

May 15, 2022

Novo Nordisk and Flagship Pioneering announce a strategic collaboration to create a portfolio of transformational medicines

Life sciences

The companies will explore opportunities to apply Flagship’s innovative bioplatforms – an ecosystem that currently comprises 41 companies – to scientific challenges in disease areas within cardiometabolic and rare diseases and initiate research programmes based on these.

May 15, 2022

BD, Babson set sights on bringing simple blood collection into the home

Life sciences

BD is expanding its long-running partnership with the blood collection company Babson Diagnostics. The two companies have been working together since 2019 on a device that can gather small volumes of blood from the capillaries in the fingertip without requiring any specialized training, and beginning with a focus on supporting primary care in retail settings.

May 15, 2022

CSL’s $11.7B Vifor buy, 2021’s biggest biopharma M&A deal, hits antitrust delay

Life sciences

Wednesday, Australian biotech CSL said (PDF) the regulatory review of its $11.7 billion acquisition of Switzerland’s Vifor Pharma will take “a few more months,” suggesting it won’t be able to close the transaction by June 2022 as previously expected.